Full-Time

Director – Marketing

Confirmed live in the last 24 hours

Revolution Medicines

Revolution Medicines

201-500 employees

Develops targeted therapies for RAS-driven cancers

Biotechnology
Healthcare

Compensation Overview

$210k - $253kAnnually

Senior

San Carlos, CA, USA

Position is based out of headquarters in Redwood City, CA.

Category
Brand & Creative Marketing
General Marketing
Growth Marketing
Growth & Marketing
Required Skills
Sales
Data Analysis
Requirements
  • Bachelor’s degree required with at least 6-8 years of progressive commercial experience in a biotechnology and/or pharmaceutical company including global strategic marketing and ideally sales.
  • Successful history of developing and executing the marketing strategy.
  • Experience building and integrating new capabilities that are relevant to launch success.
  • Demonstrated ability to derive insights/analytics leading to the development of innovative marketing strategies.
  • Strong leadership, with the ability to work well cross-functionally and influence across an organization at all levels.
  • Excellent organizational skills and an ability to prioritize effectively to deliver results within reasonably established timelines.
  • Ability to represent Revolution Medicines well externally: strong interpersonal skills including verbal and written communication.
  • Entrepreneurial mindset, with a tolerance for ambiguity, and a passion for helping cancer patient.
Responsibilities
  • Operate as an ambassador of the company, establishing the organization as a trusted member of the healthcare community to all relevant stakeholders (Patients, HCPs, Payers, Policy makers, Industry peers).
  • Establish vision for the lifecycle of the brand with portfolio considerations.
  • Lead the development effective strategic and promotional plans, and shape strategy to align with the overall launch, full brand, and portfolio strategy.
  • Develop, prioritize, and implement market development efforts that deepen awareness of unmet needs and address knowledge gaps among customers, laying the foundation for a successful product launch.
  • Leverage a strong understanding of oncology healthcare customers, including providers, key opinion leaders, patients, and market access stakeholders, to inform the go-to-market approach that drives customer behavior change and market performance.
  • Develop KPIs and continually assess performance; analyze market, customer, and competitor trends, incorporating insights into marketing strategies and plans.
  • Partner closely and provide direction to cross-functional groups (e.g. Analytics & Insights, Medical Affairs) to inform the development and implementation of integrated strategic plans.
  • Independently and credibly represent the Commercial Development and Marketing organizations on cross-functional workstreams and initiatives, ensuring appropriate alignment with launch and marketing strategies.
  • Lead prioritized execution plan across key marketplace stakeholders, e.g., HCPs, Patients, Advocacy, Health System, or other Business Partners, as needed.
  • Operate as a leader to facilitate cohesive commercial collaboration.
  • Lead critical cross-functional workstreams to ensure launch success.
  • Ensure management of partner agency of record relationships, workflow, and budgets
  • Ensure strategic and tactical plans meet compliance and regulatory guidelines and company policies.
  • Deliver marketing operating expenses within budget.
  • Travel as needed.
  • Other duties as assigned.

Revolution Medicines develops treatments specifically for cancers caused by RAS gene mutations, which are common in difficult-to-treat cancers like pancreatic, colorectal, and lung cancers. Their main product line includes RASON Inhibitors, designed to target and inhibit RAS proteins that contribute to cancer growth. The company uses a Tri Complex Inhibitor platform to create these specialized therapies. Unlike many competitors, Revolution Medicines focuses solely on RAS-driven cancers, allowing them to carve out a niche in the oncology market. Their goal is to transform cancer treatment by providing effective targeted therapies for patients suffering from these challenging conditions.

Company Stage

IPO

Total Funding

$219.8M

Headquarters

Redwood City, California

Founded

2014

Growth & Insights
Headcount

6 month growth

15%

1 year growth

42%

2 year growth

137%
Simplify Jobs

Simplify's Take

What believers are saying

  • The acquisition of EQRx is expected to add over $1 billion in net cash, significantly bolstering Revolution Medicines' financial position.
  • Successful public offerings and underwriters' full exercise of options have brought substantial capital, indicating strong investor confidence.
  • The company's innovative RASON Inhibitors and Tri Complex Inhibitor platform have the potential to revolutionize treatment for RAS-driven cancers, offering significant clinical impact.

What critics are saying

  • The highly specialized focus on RAS-driven cancers may limit market size and revenue potential compared to broader oncology companies.
  • Integration challenges from the acquisition of EQRx could divert focus and resources, potentially impacting ongoing projects.

What makes Revolution Medicines unique

  • Revolution Medicines focuses exclusively on RAS-driven cancers, a niche but critical area in oncology, unlike broader-spectrum oncology companies.
  • Their Tri Complex Inhibitor platform allows for highly specialized treatments, setting them apart from competitors with more generalized approaches.
  • The company's revenue model, which includes licensing, co-development partnerships, and direct sales, provides multiple revenue streams, enhancing financial stability.

Help us improve and share your feedback! Did you find this helpful?